当前位置: X-MOL 学术J. Chromatogr. B › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Simultaneous determination of a novel oxazolidinone anti-tuberculosis OTB-658 and its metabolites in monkey blood by LC-MS/MS
Journal of Chromatography B ( IF 2.8 ) Pub Date : 2021-01-18 , DOI: 10.1016/j.jchromb.2021.122552
Jianwei Jiang , Yuke Liu , Xiao Liu , Dongfeng Zhang , Haihong Huang , Baolian Wang , Li Sheng , Yan Li

OTB-658, a novel oxazolidinone anti-tuberculosis agent, has potent antibacterial activity against Mycobacterium tuberculosis, especially multi-drug resistant tuberculosis (MDR-TB) in vitro and in vivo. In this study, after metabolite identification of parent drug OTB-658, a specific and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was established and validated to quantify OTB-658 and its metabolites OTB-665 and OTB-698 in monkey blood. HHY-1442, an analogue compound of OTB-658, was used as the internal standard. Blood samples were prepared by direct protein precipitation. Separation was performed on a Zorbax SB C18 column (50 mm × 2.1 mm, 3.5 μm) with a gradient mobile phase of methanol/water at a flow rate of 0.3 mL/min. The detection was conducted by a positive electrospray ionization in multiple-reaction monitoring mode on a triple quadrupole MS. The monitored transitions were m/z 382.2 → 221.1 for OTB-658, m/z 398.2 → 308.1 for OTB-665, m/z 414.1 → 372.3 for OTB-698 and m/z 418.2 → 311.3 for HHY-1442, respectively. Good linearity was observed over the range of 10–2000 ng/mL for OTB-658 and OTB-665, and 5–1000 ng/mL for OTB-698. All the intra-day and inter-day precision for the three analytes was below 8.4%, and the accuracy ranged from 96.0% to 106.0%. All analytes were stable during storage, preparation, and analytical procedures. The validated method was successfully applied to pharmacokinetic and bioavailability studies of OTB-658 in cynomolgus monkeys and the absolute bioavailability of OTB-658 was 25.0% at an oral dose of 10 mg/kg.



中文翻译:

LC-MS / MS同时测定猴血中新型恶唑烷酮抗结核药OTB-658及其代谢物

OTB-658是一种新型恶唑烷酮抗结核药,在体外体内结核分枝杆菌,特别是耐多药结核病(MDR-TB)具有有效的抗菌活性。在这项研究中,在确定母体药物OTB-658的代谢物后,建立了一种特异性灵敏的液相色谱-串联质谱(LC-MS / MS)方法,并验证了该方法可定量OTB-658及其代谢物OTB-665和OTB-猴血698。HTB-1658的类似物HHY-1442被用作内标。通过直接蛋白质沉淀制备血液样品。在Zorbax SB C18色谱柱(50 mm×2.1 mm,3.5μm)上进行分离,使用甲醇/水的梯度流动相,流速为0.3 mL / min。通过在三重四极杆MS上以多重反应监测模式进行正电喷雾电离进行检测。所监测的转变为/ ž 382.2→221.1为OTB-658,/ž 398.2→308.1为OTB-665,/ ž 414.1→372.3为OTB-698和/ ž分别418.2→311.3为HHY-1442,。对于OTB-658和OTB-665,在10-2000 ng / mL的范围内,对于OTB-698,在5-1000 ng / mL的范围内,观察到良好的线性。三种分析物的日内和日间精度均低于8.4%,精度范围为96.0%至106.0%。在储存,制备和分析过程中,所有分析物均稳定。经验证的方法已成功应用于OTB-658在食蟹猴中的药代动力学和生物利用度研究,口服剂量10 mg / kg时,OTB-658的绝对生物利用度为25.0%。

更新日期:2021-02-15
down
wechat
bug